Technology
Health
Pharmaceutical
DURECT
$0.70839876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.7083
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0027 (0.36%) Today
-$0.0372 (-4.99%) After Hours
Why Robinhood?
You can buy or sell DURECT and other stocks, options, ETFs, and crypto commission-free!
About
DURECT Corporation Common Stock, also called DURECT, is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Read More Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Employees
88
Headquarters
Cupertino, California
Founded
1998
Market Cap
121.04M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
487.57K
High Today
$0.768
Low Today
$0.70
Open Price
$0.74
Volume
174.65K
52 Week High
$2.25
52 Week Low
$0.46
Collections
Technology
Health
Pharmaceutical
Biopharmaceutical
Manufacturing
US
North America
News
Price Paid on Robinhood
21% Lower
Right Now
52 Week Low
$0.46
Average Price Paid
$0.8952
52 Week High
$2.25
Earnings
-$0.06
-$0.02
$0.01
$0.05
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.05 per share
Actual
-$0.04 per share